🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.149,36 USD

Máx. histórico

1.292,65

16 días

Split 2:1 del 16/10/1997

Caída desde máximo

-11,08%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-0,88%

Cierre anterior

1.159,60

Rango de hoy

1.138,31 – 1.158,43

Volumen hoy

2.159.931

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
38,61 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 días
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,58%
Fecha de pago Importe por participación
08/02/1974 0,0147 USD
12/11/1973 0,0129 USD
13/08/1973 0,0129 USD
14/05/1973 0,0118 USD
09/02/1973 0,0118 USD
13/11/1972 0,0114 USD
07/08/1972 0,0114 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/11/2008 32,90 33,36 31,83 32,80 +2,24% 4,65% 6.495.500
24/11/2008 30,90 32,76 30,51 32,08 +5,42% 7,28% 7.845.200
21/11/2008 30,23 30,57 28,62 30,43 +1,74% 6,45% 9.947.500
20/11/2008 31,23 32,25 29,59 29,91 -4,78% 8,52% 7.966.700
19/11/2008 33,16 33,97 31,10 31,41 -5,79% 8,66% 7.163.500
18/11/2008 32,90 33,34 31,54 33,34 +3,77% 5,47% 6.581.300
17/11/2008 31,71 32,93 31,50 32,13 +0,22% 4,51% 6.436.700
14/11/2008 32,78 33,89 32,05 32,06 -6,04% 5,61% 8.113.700
13/11/2008 32,24 34,50 31,76 34,12 +6,66% 8,50% 13.039.100
12/11/2008 33,25 33,42 31,85 31,99 -5,83% 4,72% 6.160.700
11/11/2008 34,73 35,25 33,63 33,97 -2,58% 4,66% 4.962.000
10/11/2008 34,77 35,50 34,41 34,87 +1,96% 3,13% 5.806.900
07/11/2008 32,89 34,37 32,89 34,20 +4,05% 4,50% 4.023.900
06/11/2008 33,89 34,17 32,60 32,87 -2,64% 4,63% 6.447.300
05/11/2008 34,74 35,43 33,55 33,76 -3,95% 5,41% 5.858.400
04/11/2008 34,75 35,64 33,65 35,15 +3,35% 5,73% 7.786.900
03/11/2008 34,44 34,54 33,54 34,01 +0,56% 2,90% 4.801.900
31/10/2008 32,63 34,55 32,63 33,82 +3,02% 5,88% 6.874.800
30/10/2008 32,97 33,10 32,26 32,83 +2,50% 2,55% 7.363.200
29/10/2008 33,32 33,67 31,83 32,03 -4,04% 5,52% 9.180.200
28/10/2008 31,07 33,47 29,90 33,38 +9,80% 11,49% 8.334.900
27/10/2008 31,30 32,60 30,40 30,40 -4,19% 7,03% 7.526.900
24/10/2008 31,99 32,80 31,14 31,73 -5,23% 5,19% 7.224.100
23/10/2008 33,99 34,00 31,26 33,48 +4,27% 8,06% 8.729.300
22/10/2008 33,61 33,63 31,40 32,11 -4,66% 6,63% 6.671.900
21/10/2008 33,71 34,64 33,05 33,68 -1,23% 4,72% 7.733.000
20/10/2008 32,56 34,10 31,77 34,10 +5,90% 7,16% 9.049.300
17/10/2008 33,29 34,12 32,14 32,20 -6,34% 5,95% 9.160.900
16/10/2008 32,69 34,66 31,50 34,38 +5,65% 9,67% 10.297.900
15/10/2008 34,65 34,99 31,93 32,54 -6,87% 8,83% 10.602.700